statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis DURECT Corporation Announces Late-Breaking Oral...

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Durect (DRRX Research Report) today. The company's shares closed yesterday at $1.34...

H.C. Wainwright Keeps Their Hold Rating on Durect (DRRX)

Q4 2023 DURECT Corp Earnings Call Transcript

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Durect reports Q4 EPS (10c), consensus (33c)

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides...

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Durect (NASDAQ:DRRX) est cens e publier ses derniers b n fices ce mercredi. Voici tout ce qu'il faut savoir propos des b n fices du quatri me trimestre publi s mercredi.
D finition de b n fices, r...

Durect: Aper u des b n fices

Durect (NASDAQ:DRRX) pubblicher i prossimi risultati degli utili questo mercoled 27 marzo. Ecco la guida essenziale di Benzinga per il rapporto sugli utili di Durect per il quarto trimestre.
Utile...

Anteprima: utili di Durect

Durect (NASDAQ:DRRX) revela su pr xima ronda de resultados este mi rcoles, 27 de marzo. Prep rate con el avance definitivo de Benzinga para las ganancias del cuarto trimestre de Durect.
 Qu son...

Avance: ganancias de Durect

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and...

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

DURECT and Charles River enter agreement for alzet in U.S., Canada...

DURECT and Charles River enter agreement for alzet in U.S., Canada

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.

Volume	177,793.00
52-Wk High	$7.46
52-Wk Low	$0.4703

DRRX Durect Corp

About

Feed

News

Sentiment

Earnings

Fundamentals